Related references
Note: Only part of the references are listed.Platelet glycoprotein VI-related clinical defects
Jane F. Arthur et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Diverging signaling events control the pathway of GPVI down-regulation in vivo
Tamer Rabie et al.
BLOOD (2007)
Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases
E. E. Gardiner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization
Aloke V. Finn et al.
CIRCULATION (2007)
The fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats
Haiquan Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Distinct antithrombotic consequences of platelet glycoprotein Ibα and VI deficiency in a mouse model of arterial thrombosis
S. Konstantinides et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents
Brian Boylan et al.
BLOOD (2006)
Two-phase antithrombotic protection after anti-glycoprotein VI treatment in mice
Valerie Schulte et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency
Pierre Mangin et al.
BLOOD (2006)
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo
Christophe Dubois et al.
BLOOD (2006)
GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism
Simon Lockyer et al.
THROMBOSIS RESEARCH (2006)
Importance of platelet phospholipase Cγ2 signaling in arterial thrombosis as a function of lesion severity
C Nonne et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen
G Stephens et al.
BLOOD (2005)
Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody
PA Smethurst et al.
BLOOD (2004)
Anti-GPVI-associated ITP:: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface
B Boylan et al.
BLOOD (2004)
Principal role of glycoprotein VI in α2β1 and αIIbβ3 activation during collagen-induced thrombus formation
C Lecut et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion
K Kato et al.
BLOOD (2003)
Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
V Schulte et al.
BLOOD (2003)
A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo
S Massberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Human platelet glycoprotein VI function is antagonized by monoclonal anti body-derived Fab fragments
C Lecut et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury
H Konishi et al.
CIRCULATION (2002)
Expression and function of the collagen receptor GPVI during megakaryocyte maturation
AH Lagrue-Lak-Hal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice
B Nieswandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRγ chain
B Nieswandt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)